{'fraction_non_alphanumeric': 0.012626262626262626, 'fraction_numerical': 0.012626262626262626, 'mean_word_length': 4.925373134328358, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Cisplatin or carboplatin for ovarian and testicular cancer?

Carboplatin was introduced in 1986 as a less toxic alternative to cisplatin. When we reviewed the drugs seven years ago1 it was not clear whether carboplatin could replace cisplatin in the treatment of cancer, and the debate has continued. In this article we compare the two products for the treatment of ovarian and testicular cancer.